European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

European equities traded in the US as American depositary receipts started the week modestly higher late Monday morning, rising 0.40% to 1,829.22 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and medical device maker EDAP TMS (EDAP), which advanced 6.2% and 5% respectively. They were followed pharmaceutical company Novo Nordisk (NVO) and software firm SAP (SAP), which increased 4.1% and 2% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and consumer goods company Unilever (UL), which dropped 3.2% and 1.3% respectively. They were followed by internet advertising firm Criteo (CRTO) and health care tech company Royal Philips (PHG), which lost 0.7% and 0.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which rose 4.9% and 2.1% respectively. They were followed by oil and gas company Shell (SHEL) and mining company BHP Group (BHP), which were up 2% each.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which shed 9.3% and 6.7% respectively. They were followed by lender Lloyds Banking Group (LYG) and software company Endava (DAVA), which were down 3.7% and 3.1% respectively.